Efficacy of N-acetylcysteine in patients with COVID-19

Phase 3

• Conditions: covid-19.; COVID-19; U07.1

• Registration Number: IRCT20200623047897N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

admitted patients with COVID-19
moderate to severe, stable patients

Exclusion Criteria

unstable and intubated ICU patients
pregnancy, breastfeeding infancy
allergy and intolerance to NAC
unstable vital signs or need for intubation

Study & Design

• Study Type: interventional
• Study Design: Not specified